AXOGEN INC (AXGN)
US05463X1063 - Common Stock
Taking everything into account, AXGN scores 3 out of 10 in our fundamental rating. AXGN was compared to 193 industry peers in the Health Care Equipment & Supplies industry. AXGN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AXGN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year AXGN has reported negative net income.
AXGN had a negative operating cash flow in the past year.
In the past 5 years AXGN always reported negative net income.
AXGN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AXGN (-11.03%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -22.70%, AXGN is in the better half of the industry, outperforming 60.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.03% | ||
| ROE | -22.7% | ||
| ROIC | N/A |
ROA(3y)-12.93%
ROA(5y)-13.89%
ROE(3y)-25.1%
ROE(5y)-23.33%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 78.46%, AXGN belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
In the last couple of years the Gross Margin of AXGN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AXGN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.46% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.11%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
AXGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AXGN has more shares outstanding
AXGN has more shares outstanding than it did 5 years ago.
AXGN has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.30, we must say that AXGN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AXGN (0.30) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.49 indicates that AXGN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.49, AXGN is not doing good in the industry: 63.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.3 |
ROIC/WACCN/A
WACC9.6%
2.3 Liquidity
A Current Ratio of 2.89 indicates that AXGN has no problem at all paying its short term obligations.
AXGN has a Current ratio (2.89) which is in line with its industry peers.
A Quick Ratio of 2.14 indicates that AXGN has no problem at all paying its short term obligations.
AXGN has a Quick ratio (2.14) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.89 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
AXGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.00%, which is quite impressive.
Looking at the last year, AXGN shows a quite strong growth in Revenue. The Revenue has grown by 14.74% in the last year.
The Revenue has been growing by 13.64% on average over the past years. This is quite good.
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-100%
Revenue 1Y (TTM)14.74%
Revenue growth 3Y12.29%
Revenue growth 5Y13.64%
Revenue growth Q2Q18.7%
3.2 Future
Based on estimates for the next years, AXGN will show a very strong growth in Earnings Per Share. The EPS will grow by 35.73% on average per year.
The Revenue is expected to grow by 12.85% on average over the next years. This is quite good.
EPS Next Y10.28%
EPS Next 2Y72.69%
EPS Next 3Y63.44%
EPS Next 5Y35.73%
Revenue Next Year13.82%
Revenue Next 2Y13.31%
Revenue Next 3Y12.76%
Revenue Next 5Y12.85%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AXGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AXGN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as AXGN's earnings are expected to grow with 63.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.69%
EPS Next 3Y63.44%
5. Dividend
5.1 Amount
No dividends for AXGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AXOGEN INC
NASDAQ:AXGN (5/3/2024, 7:00:01 PM)
After market: 5.74 -0.05 (-0.86%)5.79
-0.09 (-1.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap253.02M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.03% | ||
| ROE | -22.7% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.46% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.89 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y10.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.74%
Revenue growth 3Y12.29%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y